Search

everythinglearnresearchcommunity

for

Search:↓

Transplant success has improved with better immunosuppressive drugs and donor matching.

Researchers created a fully functional, bioengineered skin system with hair from stem cells that successfully integrated when transplanted into mice.

Higher TGF-β signaling may increase skin cancer risk in organ transplant recipients.

Scientists successfully created and transplanted bioengineered hair follicles that function like natural ones, suggesting a new treatment for hair loss.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Scientists made working salivary glands in mice using bioengineered cells, which could help treat dry mouth.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Peanut allergies can be transferred through organ transplants.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Pharmaceutical care in transplantation faces challenges but has promising future opportunities for better outcomes.

Transplant patients often get skin problems, with treatments varying by condition.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Renal transplant patients on tacrolimus and sirolimus may develop acne keloidalis nuchae.

The document concludes that transplantology has evolved with improved techniques and materials, making transplants more successful and expanding the types of transplants possible.

The review concludes that innovations in regenerative medicine, tissue engineering, and developmental biology are essential for effective tissue repair and organ transplants.

A woman developed thick gums from everolimus treatment after a kidney transplant.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

New hair regrowth model introduced, imiquimod kills skin cancer cells, T-cadherin loss makes skin cancer more invasive, no strong link between PTCH1 gene and skin cancer after transplant, and male teens more likely to have hereditary hair loss.

New hair regrowth model proposed, imiquimod found to kill skin cancer cells, T-cadherin loss linked to invasive skin cancer, no clear gene link to skin cancer after transplant, and study on children's hair loss shows male dominance and genetic ties.

Skin issues can indicate immune system problems.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

Bioprinting could greatly improve health outcomes but faces challenges like material choice and ensuring long-term survival of printed tissues.

Vitamin D has potential benefits for cancer prevention, heart health, diabetes, obesity, muscle function, skin health, and immune function, but clinical results are mixed and more research is needed.

Cyclosporine A was found to increase hair growth in mouse whisker follicles.

Pediatric transplant patients often experience unique skin changes mainly due to medication use.